PERCEPTIVE ADVISORS LLC
Top Portfolio Positions
90 positions ·
$5,091,752,531 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
2,035,986 | $655,974,329 | 12.88% | |
| CELC |
Celcuity Inc.
Healthcare
|
3,127,200 | $356,938,608 | 7.01% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
1,531,421 | $350,281,925 | 6.88% | |
| ROIV |
Roivant Sciences Ltd.
Healthcare
|
8,285,461 | $229,507,269 | 4.51% | |
| CNTA |
Centessa Pharmaceuticals plc
Healthcare
|
5,258,903 | $208,883,627 | 4.10% | |
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
2,373,795 | $206,448,951 | 4.05% | |
| SYRE |
Spyre Therapeutics, Inc.
Healthcare
|
3,783,225 | $190,825,869 | 3.75% | |
| NUVL |
Nuvalent, Inc.
Healthcare
|
1,580,505 | $161,922,737 | 3.18% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
4,423,974 | $139,355,181 | 2.74% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
1,230,879 | $129,734,646 | 2.55% |
Portfolio Trend
26 quarters · across all stocks
Holdings in FOLD
Shares Held
Position Value (USD)
23 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $90,720,918 | 6,370,851 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $50,202,305 | 6,370,851 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $42,475,515 | 7,412,830 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $175,150,540 | 21,464,527 | Shares | Sole | 2025-08-06 | |
| 2024-09-30 | $299,653,630 | 28,057,456 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $278,329,963 | 28,057,456 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $330,516,831 | 28,057,456 | Shares | Sole | 2024-08-06 | |
| 2023-12-31 | $398,135,300 | 28,057,456 | Shares | Sole | 2024-02-26 | |
| 2023-09-30 | $336,745,870 | 27,692,917 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $347,446,237 | 27,662,917 | Shares | Sole | 2023-08-24 | |
| 2023-03-31 | $306,781,749 | 27,662,917 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $337,520,016 | 27,642,917 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $285,773,253 | 27,372,917 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $288,858,013 | 26,895,532 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $260,953,852 | 27,555,845 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $306,761,566 | 26,559,443 | Shares | Sole | 2022-04-13 | |
| 2021-09-30 | $253,642,680 | 26,559,443 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $222,889,611 | 23,121,329 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $225,869,930 | 22,861,329 | Shares | Sole | 2021-08-13 | |
| 2020-12-31 | $579,837,188 | 25,112,048 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $354,723,317 | 25,122,048 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $379,750,049 | 25,182,364 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $232,685,043 | 25,182,364 | Shares | Sole | 2020-05-18 | |
| No 13F history on record for this holder in this stock. | ||||||